Findings
RF wireless technologies in medical devices must account for crowded RF environments, coexistence issues, and risks associated with data loss, interference, and security breaches.
The quality of wireless signals (QoS) is critical for devices with time-sensitive or critical functionalities, such as alarms and life-support systems.
Electromagnetic compatibility (EMC) testing must address both emissions and immunity, ensuring devices can operate safely in shared RF environments.
Device labeling must inform users about potential interference, wireless security measures, and operating limitations in specific environments.
Postmarket risk management must address failure trends related to RF wireless performance, incorporating corrective and preventive actions to maintain safety.

Recommendations
Design Considerations: Use risk management practices to evaluate wireless technologies and determine appropriate risk mitigation strategies.
Limit RF output power to the minimum necessary to ensure functionality and reduce interference risks.
Testing and Validation: Conduct coexistence testing to evaluate performance in environments with other RF systems.
Perform EMC immunity testing under real-world operating conditions.
Security Measures: Implement encryption and authentication protocols to protect against unauthorized access.
Disable automatic connection modes (e.g., Bluetooth™ discovery) for safety-critical applications.
Premarket Submissions: Include a detailed description of the device’s wireless functions, risk mitigations, and testing protocols.
Summarize test results, including coexistence, EMC, and security assessments.
Labeling and User Instructions: Provide clear guidance on device setup, operation, and troubleshooting.
Include warnings about potential RF interference and instructions for maintaining signal quality and security.

Regulatory Considerations
Premarket submissions must include a description of the wireless technology, its intended use, and test data demonstrating compliance with standards.
EMC testing must conform to recognized consensus standards, such as IEC 60601-1-2, with modifications to address wireless technology.
FDA requires labeling to include information on operating frequencies, effective radiated power, and mitigation strategies for coexistence and security.
Postmarket risk management must analyze failure trends and implement corrective actions to address RF-related performance issues.
Compliance with Federal Communications Commission (FCC) regulations, including frequency band allocation and RF emission limits, is mandatory.